A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Seoul National University Hospital
Instituto do Cancer do Estado de São Paulo
Kestrel Therapeutics, Inc.
Astellas Pharma Inc
J-Pharma Co., Ltd.
Hoosier Cancer Research Network
National Institutes of Health Clinical Center (CC)
Tango Therapeutics, Inc.
Assistance Publique - Hôpitaux de Paris
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Jazz Pharmaceuticals
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Eli Lilly and Company
Rigel Pharmaceuticals
Alentis Therapeutics AG
City of Hope Medical Center
University Hospital, Angers
M.D. Anderson Cancer Center
West China Hospital
Yale University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Servier
Arvinas Inc.
Case Comprehensive Cancer Center
Myeloid Therapeutics
New Phase Ltd.
Stanford University
University of Kentucky
Oslo University Hospital
DualityBio Inc.
Bold Therapeutics, Inc.
Big Ten Cancer Research Consortium
Genfit
Massachusetts General Hospital
Aichi Medical University
Apollo Therapeutics Ltd
Taiho Oncology, Inc.
West China Hospital
Mayo Clinic
University of Maryland, Baltimore
Nantes University Hospital
RenJi Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
West China Hospital